Change of Name

Recorded: 2023-12-13 Pages: 3

Assignor

IMPEL NEUROPHARMA INC.

Executed: 2022-04-15

Assignee

IMPEL PHARMACEUTICALS INC.

201 ELLIOTT AVENUE WEST, SUITE 260, SEATTLE, WASHINGTON, 98119

Covered Property (1)

In-line Nasal Delivery Device

Application: 18/297,601 →

Publication: US 2023/0241334

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.